The slip
PARKINSON RECEIPTno. 2188
18 Oct 2026, 16:16 UTColigodendrocytes, braak
predictionPDZRN4 in oligodendrocytes tracks Braak Lewy-body stage
registeredcb3b7f315f037cb3
discovery-0.46 p=0.209 n=9
replication+0.16 p=0.689 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.46, p 0.209)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT57f46db53d16029cd648e9b9…
follows e09495d74638…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 2188: PDZRN4 in oligodendrocytes, braak
- power
- full sample -0.08 (p 0.767, n 18), 95% CI -0.52 to +0.41. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.01 (p 0.969, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.10 (p 0.683, n 18). could be the mix.
- skeptic
- leave-one-out range -0.21 to +0.03, sign flips 3; without severely affected donors -0.08 (p 0.767, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PDZRN4 in oligodendrocytes.
case closed: nothing better to follow up.